Anebulo Pharmaceuticals I...
1.63
-0.01 (-0.61%)
At close: Jan 15, 2025, 12:59 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY24 FY23 FY22 FY21 FY20
PE Ratio -8.44 -5.02 -17.82 -5.26 -964.21
PS Ratio n/a n/a n/a n/a n/a
PB Ratio 18.15 5.56 8.06 7.44 -983.93
P/FCF Ratio -8.55 -6.09 -22.33 -32.68 -1.12K
P/OCF Ratio -8.55 -6.09 -22.33 -32.68 -1.12K
OCF/S Ratio n/a n/a n/a n/a n/a
Debt / Equity Ratio n/a n/a n/a n/a -1.18
Quick Ratio 13.46 21.04 28.39 82.71 13.53
Current Ratio 13.46 21.04 28.39 82.71 13.53
Asset Turnover n/a n/a n/a n/a n/a
Interest Coverage n/a n/a -931.69 -307.11 -134.8
Return on Equity (ROE) -2.15 -1.11 -0.45 -1.41 1.02
Return on Assets (ROA) -2.01 -1.01 -0.44 -1.4 -0.06
Return on Capital (ROIC) -2.18 -1.06 -0.45 -0.17 -0.06
Dividend Yield n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a